The Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis

Respiratory Medicine

Volumn 102, Issue 4, 2008, Pages 586-592

  Manali, Effrosyni D ^a   Stathopoulos, Georgios T ^b   Kollintza, Androniki ^b   Kalomenidis, Ioannis ^a   Emili, Joseph Milic ^c   Sotiropoulou, Christina ^b   Daniil, Zoe ^d   Roussos, Charis ^b   Papiris, Spyros A ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b Pulmonary Services   (Greece)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF THESSALY   (Greece)

Author keywords

Fibrosis; Lung; Medical Research Council chronic dyspnea score; Prognosis; Pulmonary function tests

Indexed keywords

AZATHIOPRINE; COLCHICINE; METHYLPREDNISOLONE;

ARTERIAL GAS; ARTICLE; DYSPNEA; FIBROSING ALVEOLITIS; HISTOLOGY; HUMAN; KAPLAN MEIER METHOD; LUNG FUNCTION TEST; MEDICAL RECORD; MEDICAL RESEARCH; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL; SURVIVAL TIME; TOTAL LUNG CAPACITY;

AGED; DYSPNEA; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LUNG; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY FIBROSIS; SURVIVAL ANALYSIS; TOTAL LUNG CAPACITY;

EID: 40049106662     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.11.008     Document Type: Article

References (36)

1. Katzenstein A.L., Zisman A.D., Litzky A.L., Nguyen B.T., and Kotloff R.M. Usual interstitial pneumonia. Histologic study of biopsy and explant specimens. Am J Surg Pathol 26 (2002) 1567-1577
2. Flaherty K.R., Travis W.D., Colby T.V., et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 164 (2001) 1722-1727
3. Selman M., King Jr. T.E., and Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications therapy. Ann Intern Med 134 (2001) 136-151
4. American Thoracic Society. European Respiratory Society, American College of Chest Physicians. Idiopathic pulmonary fibrosis, diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 161 (2000) 646-664
5. Latsi P., Du Bois R., Nicholson A., et al. Fibrotic idiopathic interstitial pneumonia. The prognostic value of longitudinal trends. Am J Respir Crit Care Med 168 (2003) 531-537
6. Flaherty K.R., Mumford J.A., Murray S., et al. Prognostic implications of physiologic and radiographic changes in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168 (2003) 543-548
7. Collard H.R., King Jr. T., Bartelson B.B., Vourlekis J.S., Schwartz M.I., and Brown K.K. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168 (2003) 538-542
8. Eltayara L., Becklake M.R., Volta C.A., and Milic-Emili J. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154 (1996) 1726-1734
9. Bestall J.C., Paoul E.A., Garrod R., Garnham R., Jones P.W., and Wedzicha J.A. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54 (1999) 581-586
10. Koulouris N.G., Retsou S., Kosmas E., et al. Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis. Eur Respir J 21 (2003) 743-748
11. Delclaux C., Zerah-Lancner F., Bachir D., et al. Factors associated with dyspnea in adult patients with sickle cell disease. Chest 128 (2005) 3336-3344
12. Papiris S.A., Daniil Z., Malagari K., et al. The Medical Research Council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis. Respir Med 99 (2005) 755-761
13. Tzanakis N., Samiou M., Lambiri I., Antoniou K., Siafakas N., and Bouros D. Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. Eur J Intern Med 16 (2005) 105-112
14. Quanjer P.H., Tammeling G.J., Cotes J.E., Pedersen O.F., Peslin R., and Yernault J.C. Lung volumes and forced ventilatory flows. Report working party, standardization of lung function tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J 6 Suppl. 16 (1993) S5-S40
15. Cotes J.E., Chinn D.J., Quanjer P.H., Roca J., and Yernault J.C. Standardization of the measurement of transfer factor (Diffusing Capacity). Report working party, standardization of lung function tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J 6 Suppl. 16 (1993) S41-S52
16. Martinez T.Y., Pereira C.A., dos Santos M., Ciconelli R.M., Guimaraes S.M., and Martinez J.A. Evaluation of the short form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis. Chest 117 (2000) 1627-1632
17. Mahler D.A., and Wells C.K. Evaluation of clinical methods for rating dyspnea. Chest 93 (1988) 580-586
18. Gay S.E., Kazerooni E.A., Toews G.B., et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med 157 (1998) 1063-1072
19. Erbes R., Schaberg T., and Loddenkemper R. Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome?. Chest 111 (1997) 51-57
20. Schwartz D.A., Scott van Fossen D., Davis C.S., et al. Determinants of progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 149 (1994) 444-449
21. Hubbard R., Johnston I., and Britton J. Survival in patients with cryptogenic fibrosing alveolitis. A population-based cohort study. Chest 113 (1998) 396-400
22. Mogulcoc N., Brutsche M.H., Bishop P.W., Greaves M., Horrocks A.W., and Egan J.J. On behalf of the greater manchester pulmonary fibrosis consortium. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med 164 (2001) 103-108
23. King Jr. T.E., Tooze J.A., Schwarz M.I., Brown K.R., and Cherniack R.M. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 164 (2001) 1171-1181
24. King T.E., Schwarz M.I., Brown K., et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 164 (2001) 1025-1032
25. Nicholson A.G., Colby T.V., du Bois R.M., Hansell D.M., and Wells A.U. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 162 (2000) 2213-2217
26. Daniil Z.D., Gilchrist F.C., Nicholson A.G., et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 160 (1999) 899-905
27. Nicholson A., Fulford L., Colby T., du Bois R.M., Hansell D.M., and Wells A.U. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 166 (2002) 173-177
28. Utz J., Ryu J., Douglas W., et al. High short term mortality following lung biopsy for usual interstitial pneumonia. Eur Respir J 17 (2001) 175-179
29. Hunninghake G., Zimmerman M., Schwartz D., et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 164 (2001) 193-196
30. Orens J.B., Estenne M., Arcasoy S., et al. International guidelines for the selection of lung transplant candidates: 2006 update; a consensus report from the pulmonary scientific council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 25 (2006) 745-755
31. Martinez F.J., and Flaherty K. Pulmonary function testing in idiopathic interstitial pneumonias. Proc Am Thorac Soc 3 (2006) 315-321
32. Tzanakis N., Samiou M., Lambiri I., Antoniou K., Siafakas N., and Bouros D. Evaluation of health-related quality of life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. EJIM 16 (2005) 105-112
33. Gay S., Kazerooni E.A., Toews G.B., et al. Idiopathic pulmonary fibrosis. Predicting response to therapy and survival. Am J Respir Crit Care Med 157 (1998) 1063-1072
34. King Jr. T., Tooze J.A., Schwarz M.I., Brown K., and Cherniack R.M. Predicting survival in idiopathic pulmonary fibrosis. Scoring system and survival model. Am J Respir Crit Care Med 164 (2001) 1171-1181
35. Martinez F.J., Safrin S., Weycker D., et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 142 (2005) 963-967
36. Walter N., Collard H.R., and King Jr. T.E. Current perspectives on the treatment of idiopathic pulmonary fibrosis. Proc Am Thorac Soc 3 (2006) 330-338